Chronic inflammatory processes are associated with a remarkable range of human diseases including numerous cardiovascular, pulmonary, neurodegenerative, and autoimmune disorders.

Advances in our understanding of inflammatory biomarkers and their role in disease offer tremendous clinical value. Myriad RBM’s multi-analyte profiling (MAP) technology provides comprehensive, quantitative and sensitive measurement of dozens of protein biomarkers involved in inflammation pathways, including cytokines, chemokines, and acute-phase reactants.

Get Access to the Application Notes